The University of Miami Health System is starting a clinical trial to further evaluate the safety and efficacy of an investigational cell therapy for the treatment of chronic motor deficit following an ischemic stroke.
Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.
Following early-stage development of a vaccine to protect against the Zika virus, a group of researchers at the University of Miami Miller School of Medicine has published its initial findings. Now, with new funding, they are moving forward with non-human primate testing and, eventually, phase I human trials.
A Florida mother is thanking University of Miami Health System doctors after they removed two benign brain tumors strangling her optic nerves and restored her sight – all while she was six months pregnant.
Researchers at Bascom Palmer Eye Institute, part of the University of Miami Miller School of Medicine, have identified a new molecule that induces the formation of abnormal blood vessels in the eyes of diabetic mice. The study suggests that inhibiting this molecule may prevent similarly aberrant blood vessels from damaging the vision of not only diabetics, but also premature infants.